More on LBRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

LB Pharmaceuticals (NQ:LBRX)
Delayed: 31.41 +0.82 (2.68%)
Prev. Close $30.59  
Open$30.11 
52 Wk High$ 
52 Wk Low$ 
Day High$32.09 
Day Low$29.36 
P/E N/A  
EPS$ 
Volume147,919 


Jul 16, 2026 04:02 PM Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
Jul 10, 2026 04:39 PM LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Jul 7, 2026 05:32 AM Wolfe Research Starts LB Pharmaceuticals Inc (LBRX) at Outperform
Jun 30, 2026 08:02 AM LB Pharmaceuticals names Christopher Zergebel as SVP of clinical ops
Jun 30, 2026 08:01 AM LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations
Jun 22, 2026 07:05 AM H.C. Wainwright Reiterates Buy Rating on LB Pharmaceuticals Inc (LBRX)
Jun 10, 2026 05:01 PM Form 424B3 LB PHARMACEUTICALS INC
Jun 10, 2026 04:17 PM Form 8-K LB PHARMACEUTICALS INC For: Jun 08
Jun 9, 2026 05:42 PM Form 144 LB PHARMACEUTICALS INC Filed by: PRENSKY ZACHARY
Jun 9, 2026 04:09 PM Form 424B3 LB PHARMACEUTICALS INC
View All Articles

Entities mentioned with LBRX

View All Entities